OP  Supporting Member (50+ posts)
Joined: Apr 2005 Posts: 58 | Has anyone heard of this study or know anyting significant about the agent? Or even the idea? I am elegible and am going to ask my medical onc. about it in May when I see him (or earlier, depending upon my patience). Seems like a good approach to continue to defeat this and there doesn't seem to be a downside, unless I am missing something. The Study title is: Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. It is defined at: http://www.clinicaltrials.gov/ct/show/NCT00079053?order=93
SCC Right Tonsil, T2N1M0, Dx 12/04, Tx 40 radiation (180 rad), 8 Chemo (carbo), Tx ended 3/15/05, Selective neck dissection 5/24/05, 22 nodes, 4 levels, no evidence of metastatic malignancy!!! :-)
| 
